Cargando…

Premarket Safety and Efficacy Studies for ADHD Medications in Children

BACKGROUND: Attention-deficit hyperactivity disorder (ADHD) is a chronic condition and pharmacotherapy is the mainstay of treatment, with a variety of ADHD medications available to patients. However, it is unclear to what extent the long-term safety and efficacy of ADHD drugs have been evaluated pri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bourgeois, Florence T., Kim, Jeong Min, Mandl, Kenneth D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090185/ https://www.ncbi.nlm.nih.gov/pubmed/25007171 http://dx.doi.org/10.1371/journal.pone.0102249

Ejemplares similares

Cardiovascular Safety Profile of Dapoxetine during the Premarketing Evaluation
por: Kowey, Peter R., et al.
Publicado: (2012)

Left to Their Own Devices: Breakdowns in United States Medical Device Premarket Review
por: Hines, Jonas Zajac, et al.
Publicado: (2010)

Time Series Analysis of the Effectiveness and Safety of Capsule Endoscopy between the Premarketing and Postmarketing Settings: A Meta-Analysis
por: Iijima, Kazuo, et al.
Publicado: (2016)

Premarket evaluation of medical devices: a cross-sectional analysis of clinical studies submitted to a German ethics committee
por: Sauerland, Stefan, et al.
Publicado: (2019)

Recent progress to shorten premarket evaluation and improve patient access to medical devices by the Pharmaceuticals and Medical Devices Agency of Japan
por: Handa, Nobuhiro, et al.
Publicado: (2019)

Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study
por: Wigal, Sharon B., et al.
Publicado: (2019)

Overview of the Premarketing and Postmarketing Requirements for Drugs Granted Japanese Conditional Marketing Approval
por: Matsushita, Shunsuke, et al.
Publicado: (2021)

Reporting of Study Participant Demographic Characteristics and Demographic Representation in Premarketing and Postmarketing Studies of Novel Cancer Therapeutics
por: Varma, Tanvee, et al.
Publicado: (2021)

Postmarket Clinical Evidence for High-Risk Therapeutic Medical Devices Receiving Food and Drug Administration Premarket Approval in 2010 and 2011
por: Rathi, Vinay K., et al.
Publicado: (2020)

Quantification of US Food and Drug Administration Premarket Approval Statements for High-Risk Medical Devices With Pediatric Age Indications
por: Lee, Samuel J., et al.
Publicado: (2021)

The Effects of Industry Sponsorship on Comparator Selection in Trial Registrations for Neuropsychiatric Conditions in Children
por: Dunn, Adam G., et al.
Publicado: (2013)

Comparative Effectiveness Research: An Empirical Study of Trials Registered in ClinicalTrials.gov
por: Bourgeois, Florence T., et al.
Publicado: (2012)

Risk of Recall Among Medical Devices Undergoing US Food and Drug Administration 510(k) Clearance and Premarket Approval, 2008-2017
por: Dubin, Jonathan R., et al.
Publicado: (2021)

Premarket Approval Through the 510(k) Process: Lessons from the Translation Process of Magnetic Resonance Elastography
por: Aponte Ortiz, Jaime A., et al.
Publicado: (2018)

The premarket assessment of the cost-effectiveness of a predictive technology “Straticyte™” for the early detection of oral cancer: a decision analytic model
por: Khoudigian-Sinani, S., et al.
Publicado: (2017)

Industry-sponsored clinical research outside high-income countries: an empirical analysis of registered clinical trials from 2006 to 2013
por: Murthy, Srinivas, et al.
Publicado: (2015)

Premarket Development Times for Innovative Vaccines––To What Extent Are the Coronavirus Disease 2019 (COVID-19) Vaccines Outliers?
por: Beall, Reed F, et al.
Publicado: (2021)

Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports
por: Chang, Lee, et al.
Publicado: (2015)

Assessing Visual Outcomes: A Comparative Study of US-FDA Premarket Approval Data for Multifocal and EDOF Lens Implants in Cataract Surgery
por: Moshirfar, Majid, et al.
Publicado: (2023)

Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018
por: Rathi, Vinay K, et al.
Publicado: (2023)

Differential Efficacy of Neurofeedback in Children with ADHD Presentations
por: Cueli, Marisol, et al.
Publicado: (2019)

The Impact of Depressive Symptoms in Adults with ADHD Symptoms on Family Function and ADHD Symptoms of Their Children
por: Hong, Soon-Beom, et al.
Publicado: (2014)

Conflict of interest disclosure in biomedical research: a review of current practices, biases, and the role of public registries in improving transparency
por: Dunn, Adam G., et al.
Publicado: (2016)

The Mechanism, Clinical Efficacy, Safety, and Dosage Regimen of Atomoxetine for ADHD Therapy in Children: A Narrative Review
por: Fu, Di, et al.
Publicado: (2022)

ADHD and Intellectual Disability: using ADHD medication
por: Courtenay, K., et al.
Publicado: (2022)

The efficacy of physical exercise interventions on mental health, cognitive function, and ADHD symptoms in children and adolescents with ADHD: an umbrella review
por: Dastamooz, Sima, et al.
Publicado: (2023)

Long-term efficacy and safety outcomes with OROS-MPH in adults with ADHD
por: Buitelaar, Jan K., et al.
Publicado: (2012)

Temporal Patterns of Medications Dispensed to Children and Adolescents in a National Insured Population
por: Olson, Karen L., et al.
Publicado: (2012)

Titrating Optimal Dose of Osmotic-Controlled Release Oral Delivery (OROS)-Methylphenidate and Its Efficacy and Safety in Korean Children with ADHD: A Multisite Open Labeled Study
por: Song, Dong-Ho, et al.
Publicado: (2012)

Estimating the Risk of Attention Deficit Hyperactivity Disorder (ADHD) in Parents of Children with ADHD and the Association with Their Children’s Disease Severity and Adherence to Medication
por: Ragadran, Jananheendaran, et al.
Publicado: (2023)

Prevalence and Characteristics of Interventional Trials Conducted Exclusively in Elderly Persons: A Cross-Sectional Analysis of Registered Clinical Trials
por: Bourgeois, Florence T., et al.
Publicado: (2016)

Occurrence of ADHD in parents of ADHD children in a clinical sample
por: Starck, Martina, et al.
Publicado: (2016)

Antiseizure medication use during pregnancy and risk of ASD and ADHD in children
por: Wiggs, Kelsey K., et al.
Publicado: (2020)

Effect of methylphenidate on functional controllability: a preliminary study in medication-naïve children with ADHD
por: Henry, Teague R., et al.
Publicado: (2022)

Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
por: Coghill, David R., et al.
Publicado: (2017)

A Phase II Double-Blind, Placebo-Controlled, Efficacy and Safety Study of SPN-812 (Extended-Release Viloxazine) in Children With ADHD
por: Johnson, Janet K., et al.
Publicado: (2019)

Children, ADHD, and Citizenship
por: Cohen, Elizabeth F., et al.
Publicado: (2009)

Effect of Methylphenidate on Sleep Parameters in Children with ADHD
por: Lee, Sang Heon, et al.
Publicado: (2012)

Evaluation of Influenza Prevention in the Workplace Using a Personally Controlled Health Record: Randomized Controlled Trial
por: Bourgeois, Florence T, et al.
Publicado: (2008)

Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity
por: Huss, Michael, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7brfoqe2h30f9q5ln4m76bmr6b